BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Catalyst Brief//FDA catalyst calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Catalyst Brief — FDA catalyst calendar
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:event-1@catalystbrief.girapphe.com
DTSTAMP:20261117T024426Z
LAST-MODIFIED:20261117T024426Z
DTSTART;VALUE=DATE:20270228
DTEND;VALUE=DATE:20270301
SUMMARY:PDUFA: Apnimed\, Inc. (APMD) — Oxnimbi (AD109)
DESCRIPTION:FDA PDUFA goal date for Oxnimbi (aroxybutynin and atomoxetine) 
 oral NDA.\nSource: https://www.sec.gov/Archives/edgar/data/1745648/0001193
 12526462171/apmd-ex99_1.htm\nhttps://catalystbrief.girapphe.com/e/1?lang=e
 n\nNot investment advice. Dates may change.
URL:https://catalystbrief.girapphe.com/e/1?lang=en
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
